Market analyst Louis Navellier has revised stock ratings for 93 blue-chip companies based on recent institutional buying pressure and financial health assessments. Key upgrades include Intel Corporation (INTC) and Illumina, Inc. (ILMN), both rated ‘A’, while CVS Health Corporation (CVS) and Amgen Inc. (AMGN) received downgrades to ‘B’.
The rating changes were announced in a post from Pivot and Flow Daily. The updated grades reflect a comprehensive analysis conducted amidst today’s volatile market conditions. Investors with interests in these stocks are encouraged to review the latest ratings.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
